CIBC Asset Management Inc Has $11.96 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

CIBC Asset Management Inc boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,427 shares of the company’s stock after buying an additional 1,362 shares during the period. CIBC Asset Management Inc’s holdings in HCA Healthcare were worth $11,960,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of HCA. Bangor Savings Bank increased its holdings in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare in the second quarter valued at $28,000. GPS Wealth Strategies Group LLC boosted its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare during the 2nd quarter worth approximately $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.7 %

HCA opened at $342.96 on Friday. The firm has a market capitalization of $86.87 billion, a P/E ratio of 15.40, a price-to-earnings-growth ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $238.82 and a one year high of $417.14. The company has a fifty day moving average price of $385.11 and a 200-day moving average price of $357.58. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on HCA shares. UBS Group increased their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Barclays cut their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Finally, Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock valued at $5,608,990 over the last 90 days. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.